0 оценок0% нашли этот документ полезным (0 голосов)
12 просмотров2 страницы
Erythropoiesis can be increased by as much as a factor of 8 if enough iron is available. Redistribution of blood vessels subserving certain nonvital areas allows more blood to flow into critical areas. Erythroid precursor cells (CFU-E) stimulated by increased hemoglobin levels.
Erythropoiesis can be increased by as much as a factor of 8 if enough iron is available. Redistribution of blood vessels subserving certain nonvital areas allows more blood to flow into critical areas. Erythroid precursor cells (CFU-E) stimulated by increased hemoglobin levels.
Erythropoiesis can be increased by as much as a factor of 8 if enough iron is available. Redistribution of blood vessels subserving certain nonvital areas allows more blood to flow into critical areas. Erythroid precursor cells (CFU-E) stimulated by increased hemoglobin levels.
1. Tissue oxygen delivery is also the major controlling factor of
erythropoiesis through the synthesis and release of erythropoietin (EPO) by the proximal tubular cells or the peritubular interstitial cells in the kidney. EPO synthesis is governed by the activation of hypoxia inducible factor-1 (HIF-1), which controls the metabolic responses of multiple gene products to hypoxia. HIF-1 binds and activates the hypoxia-responsive transcriptional enhancer in the erythropoietin gene regulatory region that upregulates EPO expression. EPO stimulates erythroid precursor cells (CFU-E [colony-forming units erythroid]), leading to increased proliferation and shortening of their maturation time. The marrow responds to increased EPO maximally in 4 to 7 days if enough iron is available. Erythropoiesis can be increased by as much as a factor of 8. Typical of an endocrine loop feedback mechanism, there is an inverse relation between the hemoglobin and EPO levels measured in the blood (Fig. 2). Although this relation holds true in simple iron deficiency, it is somewhat distorted in the anemia associated with inflammation or chronic disease, in which there may be a blunted EPO response. This has made prediction of the hemoglobin response to treatment with exogenous EPO unpredictable, except in limited circumstances 2. Decreased hemoglobin oxygen affinity Increased oxygen extraction of anemic blood by the tissues produces increased concentration of deoxyhemoglobin in the rbc, which stimulates the production of 2,3-diphosphoglycerate (2,3-DPG). 2,3-DPG shifts the hemoglobin-oxygen dissociation curve to the right, thus allowing the tissues to more easily strip the hemoglobin of its precious electronaccepting cargo:
3. Redistribution of blood flow In anemia selective vasoconstriction
of blood vessels subserving certain nonvital areas allows more blood to flow into critical areas. The main donor sites who sacrifice their aerobic lifestyle are the skin and kidneys. Shunting of blood away from cutaneous sites is the mechanism behind the clinical finding of pallor, a cardinal sign of anemia. Although the kidney can hardly be
thought of as a nonvital area, it receives (in the normal state) much
more blood flow than is needed to meet its metabolic requirements. Although (by definition) total body red cell mass is decreased in anemia, in the chronically anemic patient the total blood volume paradoxically is increased, due to increased plasma volume. It is as if the body were trying to make up in blood quantity what it lacks in quality. 4. Increased cardiac output The heart can respond to tissue hypoxia by increased cardiac output. The increased output is matched by decreased peripheral vascular resistance and decreased blood viscosity (thinner blood flows more freely than thick blood), so that cardiac output can rise without an increase in blood pressure. Generally, anemia must be fairly severe (hemoglobin < 7 g/dL) before cardiac output rises.